Showing results (211-220 of 353) with videos related to

Sort By:
Pageof 36
Annals of the Rheumatic Diseases|January 3, 2024
Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritisJoshua F Baker, James R ODell, Bryant R England, et al.
Annals of the American Thoracic Society|October 7, 2020
Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. VeteransJake G Natalini, Joshua F Baker, Namrata Singh, et al.
Frontiers in Immunology|December 10, 2025
Malondialdehyde-acetaldehyde modified macromolecules and resulting autoantibodies in rheumatoid arthritis pathogenesis: a Systematic Literature ReviewWenxian Zhou, Nozima Aripova, Hannah J Johnson, et al.
JAMA Internal Medicine|July 31, 2023
Aortic Stenosis Risk in Rheumatoid ArthritisTate M Johnson, Chetaj A Mahabir, Yangyuna Yang, et al.
Arthritis Care & Research|May 19, 2022
Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine LearningBryant R England, Yangyuna Yang, Punyasha Roul, et al.
BMC Rheumatology|January 17, 2025
Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritisKate Tokareva, Alexander C Peterson, Aaron Baraff, et al.
Arthritis Care & Research|May 25, 2012
Body mass index and the rheumatoid arthritis swollen joint count: an observational studyLiron Caplan, Lisa A Davis, Christina M Bright, et al.
Clinical Rheumatology|October 4, 2018
Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survivalBryant R England, Harlan Sayles, Kaleb Michaud, et al.
Plos One|August 2, 2016
Toll-Like Receptor 4 Signaling Pathway Mediates Inhalant Organic Dust-Induced Bone LossElizabeth Staab, Geoffrey M Thiele, Dillon Clarey, et al.
Joint Bone Spine|June 9, 2026
Certolizumab Inhibits Radiographic Progression in Patients with Early Rheumatoid Arthritis and High Rheumatoid Factor Levels: A Pooled, Post‑Hoc Analysis of the Phase 3 C‑EARLY and C‑OPERA TrialsJosef S Smolen, Peter C Taylor, Gerd Burmester, et al.
Pageof 36